# Plain Language Summary: Preventing Overdoses and Saving Lives Act 2.0

This bill extends and expands federal funding programs designed to help prevent opioid overdose deaths. Specifically, it renews two major grant programs that give money to states, cities, tribes, and health organizations to fight the opioid crisis, extending funding through 2027. The bill removes caps on how much money individual grants can receive, meaning communities could potentially get more federal support than they could before.

The bill makes it easier for these grant programs to reach more people and organizations. Instead of limiting grants only to states, the money can now go directly to cities, territories, tribal nations, and other local groups. These recipients can then share the money with health centers, addiction treatment programs, doctors, and nonprofits working on the ground. The bill also encourages doctors to prescribe overdose-reversal medications (like Narcan) alongside opioid painkillers, so patients have immediate access to life-saving treatment if they overdose. It specifically calls out patients taking both opioids and benzodiazepines—a particularly dangerous combination—as a priority group.

On a practical level, this means communities will have more resources to distribute overdose-reversal medications, connect people who've overdosed with treatment programs, and educate the public about overdose prevention. The bill requires that at least 20 percent of grant money go toward making overdose-reversal drugs more affordable and accessible to people who need them. It also gives federal officials flexibility to waive certain rules if state or local laws would otherwise prevent communities from using the money effectively. For people struggling with opioid addiction or their families, this bill aims to make life-saving medications and treatment more available in their communities.

Preventing Overdoses and Saving Lives Act 2.0

Hill, J. French

Preventing Overdoses and Saving Lives Act 2.0 This bill reauthorizes through FY2027, modifies eligibility for, and otherwise makes changes to grants for increasing access to emergency treatments to reverse opioid overdoses (e.g., naloxone).